{"title":"抑制二肽基肽酶4 (DPP4)激活肝细胞癌免疫细胞趋化","authors":"Kristina Kovacovicova, Manlio Vinciguerra","doi":"10.1016/j.onsig.2019.08.001","DOIUrl":null,"url":null,"abstract":"<div><p>A recent work by Nishina et al. provides new evidence that DPP4 inhibitors exert antitumor effects against hepatocellular carcinoma (HCC) by orchestrating immune responses.</p></div>","PeriodicalId":92564,"journal":{"name":"Oncology signaling","volume":"2 ","pages":"Pages 1-3"},"PeriodicalIF":0.0000,"publicationDate":"2019-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.onsig.2019.08.001","citationCount":"3","resultStr":"{\"title\":\"Inhibition of dipeptidyl peptidase 4 (DPP4) activates immune cells chemotaxis in hepatocellular carcinoma\",\"authors\":\"Kristina Kovacovicova, Manlio Vinciguerra\",\"doi\":\"10.1016/j.onsig.2019.08.001\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>A recent work by Nishina et al. provides new evidence that DPP4 inhibitors exert antitumor effects against hepatocellular carcinoma (HCC) by orchestrating immune responses.</p></div>\",\"PeriodicalId\":92564,\"journal\":{\"name\":\"Oncology signaling\",\"volume\":\"2 \",\"pages\":\"Pages 1-3\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/j.onsig.2019.08.001\",\"citationCount\":\"3\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Oncology signaling\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2542563319300117\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Oncology signaling","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2542563319300117","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Inhibition of dipeptidyl peptidase 4 (DPP4) activates immune cells chemotaxis in hepatocellular carcinoma
A recent work by Nishina et al. provides new evidence that DPP4 inhibitors exert antitumor effects against hepatocellular carcinoma (HCC) by orchestrating immune responses.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
